Please login to the form below

Not currently logged in
Email:
Password:

Minoryx Therapeutics adds to board of directors

Dr Claude Nicaise joins as an independent board member

Minoryx Therapeutics Dr Claude NicaiseDr Claude Nicaise has joined Barcelona, Spain-based Minoryx Therapeutics as an independent board member.

He brings over 30 years of regulatory strategy expertise to the orphan diseases specialist, and currently also serves as a board member at Sarepta Therapeutics.

Dr Nicaise founded Clinical Regulatory Services, a biotech-focused advisory service, in 2014, having previously served as senior vice president of strategic development and global regulatory affairs at Alexion Pharmaceuticals from 2008.

Prior to this, Dr Nicaise was vice president of development at Bristol-Myers Squibb, having held a series of regulatory and project leadership positions since joining as director of clinical cancer research in 1984.

Khalid Islam, chairman of the board at Minoryx Therapeutics, said: “We are delighted to have Dr Nicaise join us as an independent board member.

“Claude's perspective, based on his distinguished career and leadership roles in R&D organisations, will be very valuable to the board as the company continues its on-going evolution.”

10th February 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics